Análisis de la producción científica sobre el síndrome de sobreposición asma – EPOC.

Saved in:

Bibliographic Details
Title:	Análisis de la producción científica sobre el síndrome de sobreposición asma – EPOC.
Alternate Title:	Analysis of scientific production on asthma – COPD overlap syndrome.
Authors:	Gonzáles Perleche, Juan José¹, Lescano Santos, Martin Nicolas¹, Garca Solórzano, Franko O.¹ fgarciaso@cientifica.edu.pe
Source:	Revista Alergia de Mexico. ene-mar2026, Vol. 73 Issue 1, p66-75. 10p.
Subjects:	DIAGNOSIS, EPIDEMIOLOGY, SCIENCE publishing, BIBLIOMETRICS, PATHOLOGICAL physiology, MONOCLONAL antibodies, RESPIRATORY diseases, THERAPEUTICS
Geographic Terms:	SOUTH Korea
Abstract (English):	BACKGROUND: Asthma-COPD overlap syndrome (ACO) is characterized by features of both asthma and COPD and is associated with a higher risk of hospital admissions. While several studies have analyzed the scientific production on asthma and COPD separately, little is known about the state of research on the overlap syndrome. OBJECTIVE: To analyze the scientific output on asthma-COPD overlap (ACO). METHODOLOGY: A bibliometric study was conducted using Scopus and Web of Science, including original articles published up to 2024. Indicators of productivity, collaboration, and impact were analyzed with the bibliometrix package in RStudio. RESULTS: A total of 436 articles on ACO were identified. The first publication appeared in 2005, and since 2013 the scientific output has grown markedly, with an annual growth rate of 8.38%. The most productive countries were South Korea (n = 330), the United States (n = 329), and China (n = 312). The thematic analysis of research on ACO showed that the main areas studied are diagnosis and vulnerable populations, as well as the epidemiology and pathophysiology of the disease, while the treatment area remains under development, particularly regarding the study of monoclonal antibodies. CONCLUSION: The analysis of scientific production on ACO reveals that, despite the sustained increase in research, significant gaps persist regarding therapeutic strategies. Furthermore, research remains limited in several countries with a high disease burden; mapping these areas and regions will be essential to foster the generation of local evidence to guide clinical and public health decision-making. [ABSTRACT FROM AUTHOR]
Abstract (Spanish):	ANTECEDENTES: El síndrome de sobreposición asma-EPOC se asocia con mayor probabilidad de ingresos hospitalarios. Aunque existen estudios que caracterizan la producción científica de asma y EPOC, poco se sabe del estado de la investigación en el síndrome que las sobreposiciona. OBJETIVO: Analizar la producción científica del síndrome de sobreposición asma-EPOC. METODOLOGÍA: Se realizó un análisis bibliométrico en Scopus y Web of Science, seleccionando artículos originales hasta el 2024. Se analizaron indicadores bibliométricos de producción, colaboración e impacto utilizado la librería de bibliometric en RStudio. RESULTADOS: Se identificaron 436 artículos relacionados con el síndrome de sobreposición asma-EPOC. La primera publicación apareció en 2005, y a partir de 2013 la producción científica incrementó notablemente, con una tasa de crecimiento de 8.38%. Los países más productivos fueron Corea del Sur (n = 330), Estados Unidos (n = 329) y China (n = 312). El análisis temático de la investigación en síndrome de sobreposición asma-EPOC mostró que las principales áreas estudiadas son el diagnóstico y población vulnerable, así como la epidemiología y fisiopatología de la enfermedad, mientras que el área de tratamiento aún se mantiene en desarrollo, especialmente en cuanto al estudio de anticuerpos monoclonales. CONCLUSIÓN: El análisis de la producción científica acerca del síndrome de sobreposición asma-EPOC revela que, a pesar del aumento sostenido en la investigación, persisten importantes vacíos en torno a estrategias terapéuticas. Además, la investigación sigue siendo limitada en varios países con alta carga de enfermedad. El mapeo de estas áreas y regiones podría ser fundamental para impulsar la generación de evidencia local que oriente decisiones clínicas y de salud pública [ABSTRACT FROM AUTHOR]
	Copyright of Revista Alergia de Mexico is the property of Coleg. Mexicano de Inmunologia Clinica y Alergia A.C.; Soc. Lat. de Alergia, Asma e Inmunologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	BACKGROUND: Asthma-COPD overlap syndrome (ACO) is characterized by features of both asthma and COPD and is associated with a higher risk of hospital admissions. While several studies have analyzed the scientific production on asthma and COPD separately, little is known about the state of research on the overlap syndrome. OBJECTIVE: To analyze the scientific output on asthma-COPD overlap (ACO). METHODOLOGY: A bibliometric study was conducted using Scopus and Web of Science, including original articles published up to 2024. Indicators of productivity, collaboration, and impact were analyzed with the bibliometrix package in RStudio. RESULTS: A total of 436 articles on ACO were identified. The first publication appeared in 2005, and since 2013 the scientific output has grown markedly, with an annual growth rate of 8.38%. The most productive countries were South Korea (n = 330), the United States (n = 329), and China (n = 312). The thematic analysis of research on ACO showed that the main areas studied are diagnosis and vulnerable populations, as well as the epidemiology and pathophysiology of the disease, while the treatment area remains under development, particularly regarding the study of monoclonal antibodies. CONCLUSION: The analysis of scientific production on ACO reveals that, despite the sustained increase in research, significant gaps persist regarding therapeutic strategies. Furthermore, research remains limited in several countries with a high disease burden; mapping these areas and regions will be essential to foster the generation of local evidence to guide clinical and public health decision-making. [ABSTRACT FROM AUTHOR]
ISSN:	00025151
DOI:	10.29262/ram.v73i1.1566